Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. scores highest on Torque (70) and lowest on Nitro (28). Its PosiPenta is 47.60 out of 100, around the middle of similar companies.
On the Penta Grid this week, Aprea Therapeutics, Inc. is Grid #324 of 837 in the Healthcare sector in United States, and Grid #2,156 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. | 47.60 | 49 | 56 | 28 | 70 | 36 |
| XWELL, Inc. | 28.18 | 0 | 35 | 41 | 15 | 50 |
| CNS Pharmaceuticals, Inc. | 42.57 | 47 | 41 | 52 | 41 | 32 |
| Imunon, Inc. | 25.70 | 31 | 39 | 19 | 9 | 30 |
| Enveric Biosciences, Inc. | 38.46 | 43 | 40 | 16 | 53 | 40 |
| ENDRA Life Sciences Inc. | 42.34 | 38 | 35 | 67 | 38 | 34 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.61 |
| P/B ratio | 0.19 |
EEarnings
| Trailing EPS | ₹-89.98 |
| Forward EPS | ₹-38.20 |
NNitro
| Price | 55.33 |
| 52-week high | 160.07 |
| 52-week low | 51.90 |
| Fall from 52-week high | 65.4% |
TTorque
| Return on equity (ROE) | -46.15% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.63 |
| Market cap | ₹69 Cr |
| Insider holding | 9.17% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Aprea Therapeutics, Inc.'s PosiPenta score?
Aprea Therapeutics, Inc.'s PosiPenta is 47.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Aprea Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Aprea Therapeutics, Inc. is Grid #324 of 837 in the Healthcare sector in United States, and Grid #2,156 of 4,000 in United States.
Which PosiPenta pillar is strongest for Aprea Therapeutics, Inc.?
Torque (durability), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Aprea Therapeutics, Inc.?
Nitro (momentum), with a score of 28 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.